Cargando…

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and Kras(G12D) Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

BACKGROUND: Cancer stem cells (CSCs) can proliferate and self-renew extensively due to their ability to express anti-apoptotic and drug resistant proteins, thus sustaining tumor growth. Therefore, the strategy to eradicate CSCs might have significant clinical implications. The objectives of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shankar, Sharmila, Nall, Dara, Tang, Su-Ni, Meeker, Daniel, Passarini, Jenna, Sharma, Jay, Srivastava, Rakesh K.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031576/ https://www.ncbi.nlm.nih.gov/pubmed/21304978 http://dx.doi.org/10.1371/journal.pone.0016530

Ejemplares similares

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
por: Tang, Su-Ni, et al.
Publicado: (2010)

Sonic Hedgehog Signaling Inhibition Provides Opportunities for Targeted Therapy by Sulforaphane in Regulating Pancreatic Cancer Stem Cell Self-Renewal
por: Rodova, Mariana, et al.
Publicado: (2012)

α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice
por: Verma, Raj Kumar, et al.
Publicado: (2016)

Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
por: Roy, Sanjit K., et al.
Publicado: (2011)

Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
por: Nalls, Dara, et al.
Publicado: (2011)

Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from Kras(G12D) Mice by Inhibiting Akt and Sonic Hedgehog Pathways
por: Huang, Minzhao, et al.
Publicado: (2014)

EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
por: Tang, Su-Ni, et al.
Publicado: (2012)

α‐Mangostin‐encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway
por: Chandra Boinpelly, Varun, et al.
Publicado: (2020)

Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor
por: Ganapathy, Suthakar, et al.
Publicado: (2010)

Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells
por: Chen, Qinghe, et al.
Publicado: (2010)

Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential
por: Shankar, Sharmila, et al.
Publicado: (2007)

Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor
por: Shankar, Sharmila, et al.
Publicado: (2008)

Inhibition of Autophagy Maintains ESC Pluripotency and Inhibits Primordial Germ Cell Formation in Chickens
por: Ding, Ying, et al.
Publicado: (2023)

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
por: Roy, Sanjit K, et al.
Publicado: (2010)

Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
por: Singh, Brahma N., et al.
Publicado: (2011)

Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1‐Cre and LSL‐Kras(G12D)) mice
por: Yu, Wei, et al.
Publicado: (2021)

Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog
por: Ma, Yiming, et al.
Publicado: (2019)

PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
por: Sharma, Narinder, et al.
Publicado: (2015)

Metabolic benefits of inhibiting cAMP-PDEs with resveratrol
por: Chung, Jay H.
Publicado: (2012)

Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
por: Adachi, Yuta, et al.
Publicado: (2021)

Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
por: Roy, Sanjit K., et al.
Publicado: (2023)

Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
por: Baribeau, Sébastien, et al.
Publicado: (2014)

Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy
por: Ishikawa, Keijiro, et al.
Publicado: (2015)

Inhibition of Mitochondrial Complex III Blocks Neuronal Differentiation and Maintains Embryonic Stem Cell Pluripotency
por: Pereira, Sandro L., et al.
Publicado: (2013)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
por: Nanta, R, et al.
Publicado: (2013)

Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition
por: Yang, Zhuying, et al.
Publicado: (2019)

Inhibition of prenylated KRAS in a lipid environment
por: Jansen, Johanna M., et al.
Publicado: (2017)

Targeting KRAS: Crossroads of Signaling and Immune Inhibition
por: Kato, Shumei, et al.
Publicado: (2022)

Chemical inhibition reveals differential requirements of signaling pathways in kras(V12)- and Myc-induced liver tumors in transgenic zebrafish
por: Yan, Chuan, et al.
Publicado: (2017)

LIN28A inhibits DUSP family phosphatases and activates MAPK signaling pathway to maintain pluripotency in porcine induced pluripotent stem cells
por: Wu, Xiao-Long, et al.
Publicado: (2021)

Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
por: Wang, Jieqiong, et al.
Publicado: (2016)

Inhibition of Epithelial-Mesenchymal Transition Maintains Stemness in Human Amniotic Epithelial Cells
por: Takano, Chika, et al.
Publicado: (2022)

Resveratrol Inhibits Protein Translation in Hepatic Cells
por: Villa-Cuesta, Eugenia, et al.
Publicado: (2011)

Inhibition of S6K by resveratrol: In search of the purpose
por: Blagosklonny, Mikhail V.
Publicado: (2009)

Role of resveratrol in inhibiting pathological cardiac remodeling
por: Fan, Shaowei, et al.
Publicado: (2022)

Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms
por: Kumar, Dhruv, et al.
Publicado: (2013)

Small-Molecule Inhibition of KRAS through Conformational Selection
por: Pagba, Cynthia V., et al.
Publicado: (2023)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2
por: Li, Xia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4sb06bphg2i8fuogjlj6d39jmq